Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Significant Decrease in Short Interest

Posted by Donna Armstrong on Mar 10th, 2026

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a large drop in short interest in February. As of February 27th, there was short interest totaling 263 shares, a drop of 94.0% from the February 12th total of 4,350 shares. Based on an average trading volume of 9,284 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 9,284 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. The Goldman Sachs Group lowered Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. Sanford C. Bernstein lowered shares of Carl Zeiss Meditec to a “market perform” rating in a research report on Monday, January 26th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

View Our Latest Stock Analysis on Carl Zeiss Meditec

Carl Zeiss Meditec Trading Down 1.8%

CZMWY stock traded down $0.52 during mid-day trading on Tuesday, hitting $28.47. 3,764 shares of the stock were exchanged, compared to its average volume of 6,445. The business has a fifty day moving average price of $36.99 and a 200 day moving average price of $45.71. Carl Zeiss Meditec has a 12 month low of $28.21 and a 12 month high of $76.28.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.